Mayo G - Search Results

1

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.

Ho RH, Choi L, Lee W, Mayo G, Schwarz UI, Tirona RG, Bailey DG, Stein CM, Kim RB. Ho RH, et al. Among authors: mayo g. Pharmacogenet Genomics. 2007 Aug;17(8):647-56. doi: 10.1097/FPC.0b013e3280ef698f. Pharmacogenet Genomics. 2007. PMID: 17622941 Free PMC article. Clinical Trial.

2

Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.

Floyd MD, Gervasini G, Masica AL, Mayo G, George AL Jr, Bhat K, Kim RB, Wilkinson GR. Floyd MD, et al. Among authors: mayo g. Pharmacogenetics. 2003 Oct;13(10):595-606. doi: 10.1097/00008571-200310000-00003. Pharmacogenetics. 2003. PMID: 14515058

3

Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition.

Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A. Schwarz UI, et al. Among authors: mayo g. Br J Clin Pharmacol. 2006 Oct;62(4):485-91. doi: 10.1111/j.1365-2125.2005.02519.x. Br J Clin Pharmacol. 2006. PMID: 16995870 Free PMC article. Clinical Trial.

4

Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.

Haas DW, Gebretsadik T, Mayo G, Menon UN, Acosta EP, Shintani A, Floyd M, Stein CM, Wilkinson GR. Haas DW, et al. Among authors: mayo g. J Infect Dis. 2009 Mar 15;199(6):872-80. doi: 10.1086/597125. J Infect Dis. 2009. PMID: 19239339 Free PMC article.

5

Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.

Johnson DH, Gebretsadik T, Shintani A, Mayo G, Acosta EP, Stein CM, Haas DW. Johnson DH, et al. Among authors: mayo g. Br J Clin Pharmacol. 2013 Apr;75(4):997-1006. doi: 10.1111/j.1365-2125.2012.04454.x. Br J Clin Pharmacol. 2013. PMID: 22957905 Free PMC article. Clinical Trial.

6

In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.

Masica AL, Mayo G, Wilkinson GR. Masica AL, et al. Among authors: mayo g. Clin Pharmacol Ther. 2004 Oct;76(4):341-9. doi: 10.1016/j.clpt.2004.07.003. Clin Pharmacol Ther. 2004. PMID: 15470333 Clinical Trial.

7

In vivo inhibition of human CYP1A2 activity by oltipraz.

Sofowora GG, Choo EF, Mayo G, Shyr Y, Wilkinson GR. Sofowora GG, et al. Among authors: mayo g. Cancer Chemother Pharmacol. 2001 Jun;47(6):505-10. doi: 10.1007/s002800000245. Cancer Chemother Pharmacol. 2001. PMID: 11459203

8

5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients.

Takahashi H, Ieiri I, Wilkinson GR, Mayo G, Kashima T, Kimura S, Otsubo K, Echizen H. Takahashi H, et al. Among authors: mayo g. Blood. 2004 Apr 15;103(8):3055-7. doi: 10.1182/blood-2003-07-2521. Epub 2003 Dec 30. Blood. 2004. PMID: 15070684 Free article.

9

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

Clarke RJ, Mayo G, Price P, FitzGerald GA. Clarke RJ, et al. Among authors: mayo g. N Engl J Med. 1991 Oct 17;325(16):1137-41. doi: 10.1056/NEJM199110173251605. N Engl J Med. 1991. PMID: 1891022 Free article. Clinical Trial.

10

Combined administration of aspirin and a specific thrombin inhibitor in man.

Clarke RJ, Mayo G, FitzGerald GA, Fitzgerald DJ. Clarke RJ, et al. Among authors: mayo g. Circulation. 1991 May;83(5):1510-8. doi: 10.1161/01.cir.83.5.1510. Circulation. 1991. PMID: 2022012 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters